Rua Bioscience Ltd
NZX:RUA

Watchlist Manager
Rua Bioscience Ltd Logo
Rua Bioscience Ltd
NZX:RUA
Watchlist
Price: 0.03 NZD Market Closed
Market Cap: 8.6m NZD
Have any thoughts about
Rua Bioscience Ltd?
Write Note

Rua Bioscience Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Rua Bioscience Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Rua Bioscience Ltd
NZX:RUA
Cost of Revenue
-NZ$204.1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BLIS Technologies Ltd
NZX:BLT
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
AFT Pharmaceuticals Ltd
NZX:AFT
Cost of Revenue
-NZ$110m
CAGR 3-Years
-19%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Cannasouth Ltd
NZX:CBD
Cost of Revenue
-NZ$2.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Greenfern Industries Ltd
NZX:GFI
Cost of Revenue
-NZ$97.6k
CAGR 3-Years
-99%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
No Stocks Found

Rua Bioscience Ltd
Glance View

Market Cap
8.6m NZD
Industry
Pharmaceuticals

Rua Bioscience Ltd. operates as a pharmaceutical company that develops medical cannabis products. The company is headquartered in Gisborne, Gisborne. The company went IPO on 2020-10-22. The firm operate in the medicinal cannabis sector commercially and is focused on producing cannabinoid derived medicines. The firm is also focusing on cultivating and developing quality-assured medicinal cannabis as active pharmaceutical ingredients.

RUA Intrinsic Value
0.001 NZD
Overvaluation 96%
Intrinsic Value
Price

See Also

What is Rua Bioscience Ltd's Cost of Revenue?
Cost of Revenue
-204.1k NZD

Based on the financial report for Jun 30, 2024, Rua Bioscience Ltd's Cost of Revenue amounts to -204.1k NZD.

What is Rua Bioscience Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 1Y
40%

Over the last year, the Cost of Revenue growth was 40%.

Back to Top